Volgen
MA van Houten
MA van Houten
Spaarne Gasthuis
Geverifieerd e-mailadres voor xs4all.nl
Titel
Geciteerd door
Geciteerd door
Jaar
Impact of delivery mode-associated gut microbiota dynamics on health in the first year of life
M Reyman, MA van Houten, D van Baarle, AATM Bosch, WH Man, ...
Nature communications 10 (1), 4997, 2019
3322019
Maturation of the infant respiratory microbiota, environmental drivers, and health consequences. A prospective cohort study
AATM Bosch, WAAS Piters, MA van Houten, MLJN Chu, G Biesbroek, ...
American journal of respiratory and critical care medicine 196 (12), 1582-1590, 2017
2752017
Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants
B Kampmann, SA Madhi, I Munjal, EAF Simões, BA Pahud, C Llapur, ...
New England Journal of Medicine 388 (16), 1451-1464, 2023
2652023
Development of upper respiratory tract microbiota in infancy is affected by mode of delivery
AATM Bosch, E Levin, MA van Houten, R Hasrat, G Kalkman, G Biesbroek, ...
EBioMedicine 9, 336-345, 2016
2592016
The impact of lockdown on pediatric ED visits and hospital admissions during the COVID19 pandemic: a multicenter analysis and review of the literature
MD Kruizinga, D Peeters, M van Veen, M van Houten, J Wieringa, ...
European journal of pediatrics 180, 2271-2279, 2021
1782021
Bacterial and viral respiratory tract microbiota and host characteristics in children with lower respiratory tract infections: a matched case-control study
WH Man, MA van Houten, ME Mérelle, AM Vlieger, MLJN Chu, ...
The Lancet Respiratory Medicine 7 (5), 417-426, 2019
1752019
Pediatric long‐COVID: An overlooked phenomenon?
CLH Brackel, CR Lap, EP Buddingh, MA van Houten, ...
Pediatric pulmonology 56 (8), 2495-2502, 2021
1622021
Effects of early-life antibiotics on the developing infant gut microbiome and resistome: a randomized trial
M Reyman, MA Van Houten, RL Watson, MLJN Chu, K Arp, WJ De Waal, ...
Nature communications 13 (1), 893, 2022
1192022
Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands
AATM Bosch, MA van Houten, JP Bruin, AJ Wijmenga-Monsuur, ...
Vaccine 34 (4), 531-539, 2016
1092016
Antibiotic utilisation for hospitalised paediatric patients
MA van Houten, K Luinge, M Laseur, JLL Kimpen
International journal of antimicrobial agents 10 (2), 161-164, 1998
1041998
The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study
JG Wildenbeest, MN Billard, RP Zuurbier, K Korsten, AC Langedijk, ...
The Lancet Respiratory Medicine 11 (4), 341-353, 2023
902023
Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial
D Barug, I Pronk, MA van Houten, FGA Versteegh, MJ Knol, ...
The Lancet Infectious Diseases 19 (4), 392-401, 2019
822019
Loss of microbial topography between oral and nasopharyngeal microbiota and development of respiratory infections early in life
WH Man, M Clerc, WAA de Steenhuijsen Piters, MA van Houten, ...
American Journal of Respiratory and Critical Care Medicine 200 (6), 760-770, 2019
772019
Molecular surveillance of nasopharyngeal carriage of Streptococcus pneumoniae in children vaccinated with conjugated polysaccharide pneumococcal vaccines
AL Wyllie, AJ Wijmenga-Monsuur, MA van Houten, AATM Bosch, JA Groot, ...
Scientific reports 6 (1), 23809, 2016
662016
SARS-CoV-2 viral-load distribution reveals that viral loads increase with age: a retrospective cross-sectional cohort study
S Euser, S Aronson, I Manders, S van Lelyveld, B Herpers, J Sinnige, ...
International journal of epidemiology 50 (6), 1795-1803, 2021
602021
Immunogenicity of the 13-valent pneumococcal conjugate vaccine in older adults with and without comorbidities in the community-acquired pneumonia immunization trial in adults …
AMM van Deursen, MA van Houten, C Webber, M Patton, DA Scott, ...
Clinical Infectious Diseases 65 (5), 787-795, 2017
552017
Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands
M Vissers, AJ Wijmenga-Monsuur, MJ Knol, P Badoux, MA Van Houten, ...
PloS one 13 (3), e0194823, 2018
542018
Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination
P Bruijning-Verhagen, MJJ Mangen, M Felderhof, NG Hartwig, ...
BMC medicine 11, 1-17, 2013
522013
Mother-to-infant microbiota transmission and infant microbiota development across multiple body sites
D Bogaert, GJ Van Beveren, EM de Koff, PL Parga, CEB Lopez, ...
Cell Host & Microbe 31 (3), 447-460. e6, 2023
432023
Meningococcal carriage in Dutch adolescents and young adults; a cross-sectional and longitudinal cohort study
MB Van Ravenhorst, MW Bijlsma, MA van Houten, VMD Struben, ...
Clinical Microbiology and Infection 23 (8), 573. e1-573. e7, 2017
432017
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20